CANNABIS reclassification

In a rapidly evolving landscape, Jamaica, New Zealand and the Isle of Man are at the forefront of significant drug policy changes, shaping the future of cannabis and substance regulations. MMJ Licensing Surges In Jamaica Jamaica's Cannabis Licensing Authority (CLA) has increased the number...

In a potentially game-changing decision, the Department of Health and Human Services (HHS) recently recommended the DEA to consider reclassifying cannabis from its Schedule I status — a classification that denotes no medical value, on par with substances like heroin — to...

"It's a watershed moment for cannabis," declared Charlie Batchell, the CEO and co-founder of Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF), during an illuminating conversation with Aaron Bry, a content producer at Benzinga. The two discussed the potentially groundbreaking reclassification...

The Department of Health and Human Services is recommending to the Drug Enforcement Administration that cannabis should be reclassified as a Schedule III controlled substance under federal law, according to a report by Bloomberg on Wednesday. Currently, cannabis is a Schedule I drug,...